Articles
Above and Beyond
Why not get paid for your refractive cataract surgery skills and services?
By Desiree Ifft, Contributing
Are Your Internet Marketing Efforts Paying Off?
Accurate tracking data can help you assess and improve your Web site.
By ROBERT C. SILKEY
at press time
The latest news
Cataract Surgeon Perspectives on the Acrysof Natural IOL
By ROBERT CIONNI, M.D.
CATARACT SURGERY: Managing Weak Zonules
Profiles of several devices and strategies that can help.
By Christopher Kent, Senior
coding & reimbursement - Coding Complex Cataract Surgery
Not all difficult surgeries qualify as "complex."
By Suzanne L. Corcoran, COE
Fluoroquinolone Update
Recent studies shed new light on penetration and wound healing.
By Christopher Kent, Senior
LASEK Gains Ground on LASIK
New techniques and post-op regimens make it a competitive alternative.
By Marguerite McDonald, MD, FACS
marketplace
Focus on Vitrectomy Systems
Monitoring Disease Treatment with Contrast Sensitivity
The test is an excellent way to confirm efficacy.
By David Evans, PhD
on the net
This site offers information on group practice management
Service Creates "Success Stories"
Raising the level of the service you provide will give you a marketing edge.
By Brad Ruden, MBA
spotlight - An Alternative to Ultrasound
The AquaLase modality of the Infiniti Vision System looks like a real contender for emulsifying cataracts.
By Christopher Kent, Senior
stat tracker
Efficiency in Cataract Surgery
Strategic Cost Containment
Spend to create practice growth and build profits, but eliminate unnecessary expenses.
By JOSEPH CARROLL
Study Turns Up the "Volume" on Debate
Surgeons object to the assertion that busy refractive practices have the greatest risk of malpractice claims.
By JOSEPH HOFFMAN
Take Benchmarking to a Higher Level
Use both internal and external standards to get a true read on practice performance.
By MARK E. KROPIEWNICKI, ESQ, LLM
The Draw of Disposables
A study suggests that single-use microkeratomes may reduce epithelial defects and enhancements.
By MICHAEL W. BELIN, M.D.
TheraTears: From Summer Project to International Brand
How Dr. Jeffrey Gilbard turned Advanced Vision Research into one of America's fastest- growing companies.
By Jerry Helzner, contributing editor
viewpoint
Retake the Board Exam Now? Me?
A Practical Look At the New Fluoroqinolones
Theoretical risk becomes a real concern with the release of a nonpreserved anti-infective.
By Randall J. Olson, M.D., Salt
Choosing Successful Glaucoma Therapy
Published studies reveal that some topical glaucoma medications lower IOP more effectively than others. Here's how you can use this information to prevent disease progression.
By Thomas E. Bournias, M.D., Chicago
Custom Ablation: 1 Year and Counting
Thousands of patients are seeing clearly thanks to wavefront-guided LASIK. Here's how custom ablation stacks up against conventional laser vision correction.
Does IntraLase Make Sense?
This surgeon responds with an unequivocal "yes" based on his experience and that of others now using the IntraLase femtosecond laser to make LASIK flaps.
By Michael Gordon, M.D., San
Education Forum Recap: Creating Compatible IOLs
Restoring crisp vision is the ultimate goal of cataract surgery. Make sure you succeed by choosing the best IOL for each patient.
Glaucoma Management Perspectives - Second in a Series of Four - Communication Is the Cornerstone Of Glaucoma Treatment
Ophthalmologists must take the time to understand glaucoma's toll on individual patients and convey to them the importance of treatment compliance in mitigating vision loss.
By LEON W. HERNDON, MD
Pumping Up Your Refractive Prowess
Wavefront technology reveals there's more to refraction than meets the phoroptor.
By Paul S. Koch, MD
Controlling Glaucoma With Early Potent Therapies
Preserving vision is a priority for patients with glaucoma. Read on to find out how you can use current research to make a difference.
By George Baerveldt, M.D.
Do You Welcome BAK? Weighing the Toxicity Risk
We must decide if the likelihood of ocular surface toxicity from a preserved antibiotic outweighs the contamination risk of one that's unpreserved.
By Frank Price, M.D., Indianapolis
Uncovering Visual Complexity
Precision wavefront technology joins other state-of-the-art diagnostic instruments in a single integrated system. Here's how it can make a difference in your practice.
By John F. Doane, MD, FACS
Detecting Glaucomatous Optic Nerve Changes
We can't afford to miss diagnostic opportunities that can facilitate timely treatment and improve quality of life for glaucoma patients. Here's what to look for.
By Steven T. Simmons, M.D.
Gatifloxacin vs. Moxifloxacin: Their Ocular Surface Effects
Study shows a nonpreserved formulation is less tolerable than a preserved anti-infective.
By Henry D. Perry, M.D., Rockville
Using Wavefront Aberrometry As a Primary Diagnostic Tool
Wavefront technology has enormous potential to become the next standard for routine refractive testing and diagnosis.
By Daniel S. Durrie, MD
Preserved Ocular Anti-infective Works as a Combination Agent
Research findings suggest preserved gatifloxacin kills multiple microbes faster than unpreserved moxifloxacin in treatment and surgical settings.
By Terrence P. O'brien, MD
To Preserve or Not to Preserve?
That is the ophthalmic anti-infective question.